4.48
-0.12 (-2.51%)
Penutupan Terdahulu | 4.59 |
Buka | 4.64 |
Jumlah Dagangan | 804,612 |
Purata Dagangan (3B) | 1,325,130 |
Modal Pasaran | 1,705,610,496 |
Harga / Pendapatan (P/E Ke hadapan) | 13.40 |
Harga / Jualan (P/S) | 2.42 |
Harga / Buku (P/B) | 2.66 |
Julat 52 Minggu | |
Tarikh Pendapatan | 26 Feb 2025 - 3 Mar 2025 |
Margin Keuntungan | -2.05% |
Margin Operasi (TTM) | 10.48% |
EPS Cair (TTM) | -0.040 |
Pertumbuhan Hasil Suku Tahunan (YOY) | 8.50% |
Pertumbuhan Pendapatan Suku Tahunan (YOY) | -88.60% |
Jumlah Hutang/Ekuiti (D/E MRQ) | 78.19% |
Nisbah Semasa (MRQ) | 5.48 |
Aliran Tunai Operasi (OCF TTM) | 155.02 M |
Aliran Tunai Bebas Leveraj (LFCF TTM) | 88.56 M |
Pulangan Atas Aset (ROA TTM) | 4.21% |
Pulangan Atas Ekuiti (ROE TTM) | -2.06% |
Arah Aliran Pasaran
Jangka Pendek | Jangka Sederhana | ||
Industri | Health Information Services (US) | Bercampur | Menurun |
Health Information Services (Global) | Bercampur | Menurun | |
Stok | GoodRx Holdings, Inc. | Menurun | Menaik |
AISkor Stockmoo
Konsensus Penganalisis | 1.0 |
Aktiviti Orang Dalam | NA |
Volatiliti Harga | 3.0 |
Purata Bergerak Teknikal | 3.5 |
Osilator Teknikal | -0.5 |
Purata | 1.75 |
GoodRx Holdings Inc is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and provides access to negotiated prices through codes that can be used to save money on prescriptions across the United States. GoodRx generates revenue from core business from pharmacy benefit managers (PBMs) that manage formularies and prescription transactions including establishing pricing between consumers and pharmacies. It also offers various healthcare products and services, including pharma manufacturer solutions, subscriptions, and telehealth services. |
|
Sektor | Healthcare |
Industri | Health Information Services |
Gaya Pelaburan | Small Core |
% Dimiliki oleh Orang Dalam | 11.90% |
% Dimiliki oleh Institusi | 70.75% |
Pemilikan
Nama | Tarikh | Syer Dipegang |
---|---|---|
Francisco Partners Management, Lp | 30 Sep 2024 | 70,078,184 |
Petrus Trust Company, Lta | 30 Sep 2024 | 2,519,726 |
Rip Road Capital Partners Lp | 30 Sep 2024 | 2,408,577 |
Technology Crossover Management X, Ltd. | 30 Sep 2024 | 1,653,566 |
Julat 52 Minggu | ||
Julat Harga Sasaran | ||
Tinggi | 7.00 (Citigroup, 56.43%) | Beli |
Median | 6.00 (34.08%) | |
Rendah | 6.00 (Morgan Stanley, 34.08%) | Pegang |
6.00 (Barclays, 34.08%) | Beli | |
Purata | 6.33 (41.45%) | |
Jumlah | 2 Beli, 1 Pegang | |
Harga Purata @ Panggilan | 4.67 |
Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
---|---|---|---|---|
Morgan Stanley | 17 Dec 2024 | 6.00 (34.08%) | Pegang | 4.46 |
Citigroup | 13 Nov 2024 | 7.00 (56.42%) | Beli | 4.66 |
Barclays | 11 Nov 2024 | 6.00 (34.08%) | Beli | 4.89 |
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
Keuntungan Nyata | - |
Keuntungan Tidak Nyata | - |
Dividen Diterima 2024 | - |
Jumlah Untung | - |
Pulangan Purata | - |
Kuantiti (Beli) | - |
Purata Harga (Beli) | - |
Kuantiti (Jual) | - |
Purata Harga (Jual) | - |